ArticleInvestigative ophthalmology & visual science2026
Exploring the Maximum Detectable Percentage of Choriocapillaris Flow Deficits Within Geographic Atrophy Using SS-OCT Angiography.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Purpose: Swept-source optical coherence tomography angiography (SS-OCTA) was used to longitudinally image eyes with AMD to determine the maximum percentage of choriocapillaris flow deficits (CCFD%) within geographic atrophy (GA). Methods: A retrospective review was performed of prospectively collected SS-OCTA images of eyes with AMD and at least one large hypertransmission defect (hyperTD). Eyes were followed up for five years, by which time unambiguous GA had developed. A grid registration strategy was used to measure the change of CCFD% at the center of atrophy and in the surrounding regions. Results: Twenty eyes were analyzed over six visits separated by 12 ± 3 months. The mean hyperTD area across 20 eyes increased from 2.90 mm2 at visit 1 to 8.59 mm2 by visit 6 (P < 0.001), whereas the CCFD% at the target box placed at the center of atrophy showed no statistically significant change with a maximum recorded value of 43.8% by the final visit. Non-target boxes were subdivided into boxes affected by hyperTDs (hyperTD boxes) and boxes unaffected by hyperTDs at any timepoint (non-hyperTD boxes). A statistically significant CCFD% difference was noted between boxes, with the hyperTD boxes showing increases over time. Conclusions: CCFDs% measurements within atrophy never showed the complete loss of CC at the center of GA. This phenomenon is likely due to the displacement of choroidal vessels into the CC slab where their angiographic signal is detected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.